Skip to Content

Newsletter No. 52 -- December 2001

ITEMS OF INTEREST TO THE IMAGING RESEARCH COMMUNITY:

CIP Web Site: http://www.cancer.gov/bip

Meeting Announcements:

  1. Third National Forum on Biomedical Imaging in Oncology, January 31 - February 1, 2002
    Location: Hyatt Arlington at Washington's Key Bridge, 1325 Wilson Boulevard, Arlington, Virginia 22209-9990 ;
    Telephone: 703-525-1234;
    FAX: 703-525-1476
    The aims are to 1) provide a forum for the exchange of information regarding the biomedical opportunities, challenges, and needs for imaging in oncology; 2) identify and begin to address industry considerations, e.g., scientific, technological, regulatory, and reimbursement; 3) facilitate the alignment of key biomedical opportunities with technology development activities
    URL: http://cancer.gov/dctd/forum/
  2. FEBRUARY CONFERENCE ON MOUSE TRANSGENICS IN HOUSTON, TEXAS (NOT-OD-02-010)
    The Office of Laboratory Animal Welfare/ NIH and the Baylor College of Medicine (BCM) will present Co-Conferences: "Care and Characterization of Genetically Engineered Mice" and "Comparative Pathology in Functional Genomics," on February 12-16, 2002, at Cullen Auditorium, BCM, in Houston, Texas. The interactive format will include lectures, demonstrations, case presentations, and poster presentations. Conference agenda and a registration form is available at:
    URL: http://www.afip.org/CLDavis/CLDavis.meetings.htm#transgenics
    URL: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-010.html
  3. SPIE MEDICAL IMAGING 2002
    February 23-28, 2002
    Town and Country Hotel, San Diego, CA
    URL: http://spie.org/conferences/calls/02/mi/
    See http://spie.org/conferences/programs/02/mi/workshops.html to view the information about Larry Clarke's session on image database resources on Sunday evening and http://spie.org/conferences/programs/02/mi/SpecialEvents.html for Lee Rosen's special session on the grants process at NIH, at the same time.

NIH

  1. NCI Bypass Budget for 2003 and Cancer Imaging Extraordinary Opportunity Specifics.
    NCI's Bypass Budget 2003
    URL: http://plan.cancer.gov/budget/2003.htm
    This is a PDF file of the entire bypass budget.
    URL http://plan.cancer.gov/pdf/bypass.pdf
    Cancer Imaging 2003 URL http://plan.cancer.gov/scipri/imaging.htm
  2. Interagency Council on Biomedical Imaging in Oncology Announcement and Call for Requests
    Next Due Date for Requests - Wednesday, February 6, 2002 (for March 20, 2002 meeting)
    The National Cancer Institute (NCI), Food and Drug Administration (FDA), and Centers for Medicare and Medicaid Services (CMS, formerly known as the Health Care Financing Administration) are pleased to announce that the sixth meeting of the Interagency Council on Biomedical Imaging in Oncology will take place on March 20, 2002. The Council is a newly created multi-agency group designed to serve as a sounding board for investigators and manufacturers attempting to take emerging medical imaging technology to market. For further information on the Interagency Council, please contact:
    Jaime Quinn,
    Division of Cancer Treatment and Diagnosis, NCI,
    301-496-6711 tel
    301-496-0826 Fax
    jquinn@mail.nih.gov
    URL: http://www.cancer.gov/scienceresources/announcements/imaging.html
  3. EARLY CLINICAL TRIALS OF IMAGING AGENTS (NCI) (SOL N01-CM-27018-45)
    Deadline: January 16, 2002
    The Biomedical Imaging Program (CIP), Division of Cancer Diagnosis and Treatment (DCTD), National Cancer Institute (NCI) plans to develop contracts to support Phase 1 (Safety) and Phase 2 (Preliminary Clinical Efficacy) clinical trials of promising imaging agents. These clinical trials will be used to rapidly evaluate the safety and diagnostic imaging capabilities of promising imaging probes, ligands, radiopharmaceuticals, and contrast agents that are of interest to NCI. It is the offeror's responsibility to monitor the above internet site for the release of this solicitation and amendments, if any. POTENTIAL OFFEROR'S WILL BE RESPONSIBLE FOR DOWNLOADING THEIR OWN COPY OF THE SOLICITATION AND AMENDMENTS. Point of contact:
    Kathleen Giuliano, Contract Specialist at
    e-mail: iuliank@mail.nih.gov/.
    Fax: 301-402-6699;
    Telephone: 301-435-3821.
    No collect calls will be accepted.
    Email kg109o@nih.gov --
    MaryAnne Golling, Contracting Officer,
    Phone (301) 435-3819,
    Fax (301) 402-6699,
    Email: mg345x@nih.gov.
    The Statement of Work is at http://rcb.nci.nih.gov/appl/rfp/27018/RFP27018-06.htm#P2268_169749
    URLs for the latest information:
    URL: http://www.eps.gov/spg/HHS/NIH/RCB/N01-CM-27018-45/listing.html
    URL: http://rcb.nci.nih.gov/appl/rfp/27018/Table%20of%20Contents.htm
  4. BROAD AGENCY ANNOUNCEMENT FOR NOVEL TECHNOLOGIES FOR NONINVASIVE DETECTION, DIAGNOSIS AND TREATMENT OF CANCER
    Solicitation Number: N01-CO-27031-16
    Current Response Date: Feb 06, 2002
    The Unconventional Innovations Program (UIP) of the National Cancer Institute (NCI) is seeking revolutionary technologies for cancer research. The UIP is soliciting proposals for the development of multifunctional technology platforms to support minimally intrusive approaches that integrate: a) sensing of the fundamental signatures of precancers, or early, metastatic, or recurring cancers in the living body, b) transmission of signature information to an external monitor, c) controlled, specific, treatment, d) monitoring of the effects of treatment. The detailed Broad Agency Announcement is available on the web site of the Research Contracts and Acquisition Branch, NCI at: http://rcb.nci.nih.gov/appl/rfp/published_rfps.jsp with instructions for submission of proposals and evaluation criteria.
    Point of Contact:
    Annmarie Keane, Contract Specialist,
    Phone (301) 435-3814,
    Fax (301) 402-6699,
    Email ak155a@nih.gov -
    Richard Hartmann, Contracting Officer,
    Phone (301) 496-8620,
    Fax (301) 402-6699,
    Email rh75f@nih.gov
    URL: http://www.eps.gov/spg/HHS/NIH/RCB/N01-CO-27031-16/SynopsisP.html
  5. DEVELOPMENT OF PET AND SPECT LIGANDS FOR BRAIN IMAGING (SBIR AWARD) (PA-02-028)
    The use of radiotracers for imaging molecular events in preclinical and clinical studies is essential for understanding the biological basis of normal brain function and the pathophysiology of brain disorders. The intent of this Program Announcement (PA) is to invite applications for the commercial development of novel radioligands for PET and SPECT imaging in human brain, and to incorporate pilot or clinical feasibility evaluation in pre-clinical studies, model development, or clinical studies.
    URL: http://grants.nih.gov/grants/guide/pa-files/PA-02-028.html
  6. NIAMS SMALL GRANT PROGRAM FOR NEW INVESTIGATORS (PAR-02-030)
    The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)is seeking small grant (R03) applications to stimulate and facilitate the entry of promising new investigators into areas of research of interest to the NIAMS. This solicitation will provide support for pilot research that is likely to lead to a subsequent individual research project grant (R01).
    URL: http://grants.nih.gov/grants/guide/pa-files/PAR-02-030.html
  7. PROBES FOR MICROIMAGING THE NERVOUS SYSTEM (SBIR AWARD) (PA-02-029)
    The National Institute of Mental Health (NIMH), National Institute on Deafness and Other Communication Disorders (NIDCD), National Institute on Neurological Disorders and Stroke (NINDS), National Institute on Aging (NIA), and National Institute of Biomedical Imaging and Bioengineering (NIBIB) invite grant applications for Small Business Innovation Research (SBIR) projects on research and development of probes useful in imaging the structure and function of the brain and other parts of the nervous system, with award duration and amounts greater than those routinely allowed under the SBIR program.
    URL: http://grants.nih.gov/grants/guide/pa-files/PA-02-029.html
  8. CHARACTERIZING, VALIDATING, AND COMPARING NEUROIMAGING INFORMATICS TOOLS (NIMH, NINDS, NIBIB) (RFA-MH-02-008)
    Letter of Intent Due: January 25, 2002;
    Application Due: February 26, 2002
    Functional magnetic resonance imaging (fMRI) is increasingly important for understanding human brain function. As with other imaging modalities, informatics tools are used at all stages of fMRI studies. As fMRI has evolved in neuroscience laboratories, investigators have created informatics tools to allow them to address particular research questions. This RFA will use the National Institutes of Health (NIH) research project grant (R01) award mechanism. The total project period for an application submitted in response to this RFA may not exceed 4 years. This RFA is a one-time solicitation.
    URL: http://grants.nih.gov/grants/guide/rfa-files/RFA-MH-02-008.html
  9. PLANNING GRANTS: NATIONAL PROGRAMS OF EXCELLENCE IN BIOMEDICAL COMPUTING (PRE-NPEBC) (PAR-00-102)
    Letter of Intent Receipt Date: October 27, February 27, and June 27 annually
    Application Receipt Date: November 27, March 27, and July 27 annually
    Participating Institutes and Centers of the National Institutes of Health (NIH) invite applications for P20 planning grants that lead to the establishment of National Programs of Excellence in Biomedical Computing. Image exploitation falls within the scope of Biomedical Computing.
    URL: http://grants.nih.gov/grants/guide/pa-files/PAR-00-102.html
  10. RESEARCH SUPPORT FOR THE PROJECT, EFFECTS OF THE CHORNOBYL ACCIDENT ON THYROID CANCER AND LEUKEMIA AND RELATED DISEASES
    Solicitation Number: NO1-CP-21009
    Current Response Date: Jan 23, 2002
    The Radiation Epidemiology Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute has a contract requirement entitled, "Research Support for the Project: Effects of the Chornobyl Accident on Thyroid Cancer and Leukemia and Related Diseases." The contract will provide technical support activities including 1) technical support to NCI staff in all disciplines associated with the implementation of three protocols (e.g., radiation epidemiology, radiation thyroidology, hematology, cytopathology, ultrasonography, clinical laboratory operations, data systems management, and statistics) and 2) technical expertise in the collection, processing and analysis of biomedical data. This work is currently being performed by Columbia University in New York under contract number NO2-CP-77032. It is anticipated that a three-year research contract will be awarded with two option years. The Request for Proposal will be issued electronically at http://rcb.nci.nih.gov under "Current Requests for Proposals" and will be available approximately December 14, 2001. Notwithstanding the 1/23/2002 proposal due dated cited elsewhere in this announcement, proposals will be due approximately 45 days after release of the Request for Proposal. No collect calls will be accepted.
    URL: http://www.eps.gov/spg/HHS/NIH/RCB/NO1-CP-21009/listing.html
  11. IMAGING EARLY MARKERS OF DIABETIC MICROVASCULAR COMPLICATIONS IN PERIPHERAL TISSUE (NIDDK, NIAMS) (RFA-DK-02-001)
    The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) solicit applications for studies designed to apply imaging techniques that measure perfusion or tissue oxygenation at the level of the microvasculature to the study of diabetes and its complications.
    URL: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-02-001.html
  12. HIGH RISK ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES RESEARCH (NIAMS) (AR-01-008)
    Letters of Intent Due: January 15, 2002;
    Application Due: February 14, 2002
    The purpose of this initiative is to broaden the base of inquiry in fundamental biomedical, bio-behavioral, and biomedical technology research by encouraging applications for research projects that involve an especially high degree of innovation and novelty and, therefore, require a preliminary test of feasibility. The research projects proposed under this Request for Applications (RFA) may involve substantial experimental risks such that their potential for highly significant outcomes may be difficult to judge by the standard criteria used in evaluating investigator initiated (R01) proposals.
    URL: http://grants.nih.gov/grants/guide/rfa-files/RFA-AR-01-008.html
  13. MENTORED CLINICAL RESEARCH SCHOLAR PROGRAM AWARD (NCRR) (RR-02-001)
    Letter of Intent Date: January 22, 2002;
    Application Receipt Date: February 20, 2002
    The purpose of the National Center for Research Resources (NCRR) Mentored Clinical Research Scholar (CRS) Program Award (K12) is to support an institutional career development program for physicians and dentists to develop the skills to become independent patient-oriented clinical investigators. Under this award, recently trained physicians and dentists will be selected to participate in an integrated didactic and mentored research program and be overseen by the Program Director and Program Advisory Committee.
    URL: http://grants.nih.gov/grants/guide/rfa-files/RFA-RR-02-001.html
  14. ELUCIDATION OF THE UNDERLYING MECHANISMS OF PLACEBO EFFECT (RFA-AT-02-002)
    The goal of this initiative is to stimulate crossing cutting, integrative research aimed at delineating the underlying mechanisms by which a placebo leads to its ultimate physiological and psychological effects. In the context of this initiative, integrative research is defined as the combined use of approaches from several different scientific disciplines such as sociology, psychology, cell biology, physiology, genetics, and/or molecular biology to probe neurological, endocrinological, immunological and other relevant systems in order to define the mechanisms underlying placebo effects.
    URL: http://grants.nih.gov/grants/guide/rfa-files/RFA-AT-02-002.html

Other Agenices

  1. AMERICAN INSTITUTE OF ULTRASOUND IN MEDICINE EDUCATION & RESEARCH FUND (ERF)
    DEADLINE FOR SUBMISSION IS JANUARY 15, 2002
    AIUM's Education and Research Fund (ERF) was created to advance education and establish research opportunities in ultrasound. The AIUM will be awarding up to four grants in 2002. Each grant will fund up to $10,000 for any one project. Researchers may apply for a grant in the following four ultrasound-related areas: 1.teaching ; 2.scientific research - obstetrical/gynecological; 3.scientific research - non-obstetrical/gynecological; 4.scientific research - basic science.
    URL: http://www.aium.org/erf/geninfo.asp
  2. AMERICAN NUCLEAR SOCIETY GRADUATE SCHOLARSHIPS
    Deadline for all entries is February 1.
    All applicants must be enrolled in an accredited institution in the United States and be U.S. citizens or possess a permanent resident visa. Academic accomplishments must be confirmed by transcript. All scholarships (except the Landis Scholarships and the Delayed Education Scholarship for Women) can be applied for on one form from ANS headquarters. (A separate form must be completed for the other two scholarships.)
    URL: http://www.ans.org/honors/scholarships/
  3. CANCER RESEARCH FOUNDATION DAMON RUNYON POSTDOCTORAL RESEARCH FELLOWSHIP
    Deadlines: March 15, August 15, December 15
    The Foundation encourages all theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention. Candidates must apply for the fellowships under the guidance of a Sponsor; a senior member of the scientific research community. The Sponsor should be actively engaged in the planning, execution and supervision of the proposed research and should encourage the Fellow to report the results of the research in scientific journals and meetings. Awards are made to institutions for the support of the Fellow under direct supervision...
    URL: http://www.cancerresearchfund.org/apFellowship.html#

___________________________________

The Cancer Imaging Program at NCI has created this e-mail distribution list to notify interested people about funding opportunities and other issues related to imaging research. Its primary purpose is to call your attention to important, relevant information on NIH Web pages, or in the NIH Guide. Occasionally it may be used to clarify areas of confusion, or disseminate answers to frequently asked questions.

If you wish to remain on the list, no action is necessary. If you wish to be added to the list (or removed from it), please contact Ms. Johnnie Smith by return e-mail (js95x@nih.gov).

Cancer Imaging Program
Division of Cancer Treatment and Diagnosis, NCI
EPN, Room 6000 - MSC-7412
6130 Executive Boulevard
Bethesda, MD 20892-7440
Tel: 301 496 9531
Fax: 301 480 3507